🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
0.4454
-0.0971 (-17.90%)
At close: Nov 20, 2026, 4:00 PM EST
0.4613
+0.0159 (3.57%)
After-hours: Nov 20, 2026, 7:59 PM EST

Humacyte Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
2.42.04--1.571.26
Revenue Growth
52.51%---23.91%-15.29%
Cost of Revenue
82.4978.488.676.5563.2661.34
Gross Profit
-80.1-76.37-88.6-76.55-61.7-60.08
Selling, General & Admin
31.8931.0725.820.3922.8821.13
Operating Expenses
29.4931.0725.820.3922.8821.13
Operating Income
-109.59-107.44-114.4-96.94-84.58-81.21
Interest Expense
-10.06-11.25-9.28-6.6-6.2-4.35
Interest & Investment Income
1.822.594.15.472.630.02
Other Non Operating Income (Expenses)
30.3138.773.92-0.260.420.06
EBT Excluding Unusual Items
-87.51-77.34-115.66-98.33-87.73-85.48
Merger & Restructuring Charges
--0.7----0.05
Other Unusual Items
-6.5537.2-33.05-12.4475.7759.06
Pretax Income
-94.76-40.83-148.7-110.78-11.97-26.48
Net Income
-94.76-40.83-148.7-110.78-11.97-26.48
Net Income to Common
-94.76-40.83-148.7-110.78-11.97-26.48
Net Income Growth
------
Shares Outstanding (Basic)
22415811810310340
Shares Outstanding (Diluted)
22415811810310340
Shares Change
56.80%33.49%14.56%0.36%157.82%593.25%
EPS (Basic)
-0.42-0.26-1.26-1.07-0.12-0.66
EPS (Diluted)
-0.42-0.26-1.26-1.07-0.12-0.66
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-88.58-105.93-99.69-75.59-72.18-81.41
Free Cash Flow Per Share
-0.40-0.67-0.84-0.73-0.70-2.04
Operating Margin
-4573.71%-5271.69%---5404.35%-6429.77%
Profit Margin
-3955.05%-2003.58%---764.54%-2096.36%
Free Cash Flow Margin
-3697.04%-5197.55%---4611.95%-6445.76%
EBITDA
-102.5-100.09-107.21-89.22-76.37-72.97
D&A For EBITDA
7.097.357.197.728.218.24
EBIT
-109.59-107.44-114.4-96.94-84.58-81.21
Revenue as Reported
2.42.04----
SEC Filings: 10-K · 10-Q